Lifestyle Interventions for Obesity—Reply

In Reply We appreciate the Letter and perspective shared by Drs Davis and Lorig in response to our Editorial on the role of lifestyle interventions for obesity in the era of glucagon-like peptide-1 receptor agonists. Although the authors agree with our perspective that there should be multiple strategies for addressing obesity, they call into question the premise that pharmacologic and surgical treatments for obesity are superior to behavioral treatments.